)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Aquestive Therapeutics
Aquestive Therapeutics (AQST) investor relations material
Aquestive Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary24 Apr, 2026
Executive summary
Annual meeting scheduled for June 10, 2026, at 9:30 AM ET, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by June 9, 2026, via online platforms.
Voting matters and shareholder proposals
Election of Gregory B. Brown, M.D., John S. Cochran, and Abigail L. Jenkins as Class II directors for three-year terms ending at the 2029 annual meeting.
Advisory vote on executive compensation for named executive officers.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Provision to address any other matters that may arise during the meeting or its adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Director nominees are proposed for staggered three-year terms to ensure continuity.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Aquestive Therapeutics
- Stockholders will vote virtually on directors, executive pay, and auditor, focusing on governance and sustainability.AQST
Proxy filing24 Apr 2026 - Anaphylm's NDA resubmission is on track for Q3, with launch prep backed by strong cash reserves.AQSTThe Citizens Life Sciences Conference 202610 Mar 2026
- Anaphylm targets Q3 2024 resubmission, with strong financials and market readiness.AQSTLeerink Global Healthcare Conference 20269 Mar 2026
- Anaphylm NDA resubmission set for Q3 2026; 2025 net loss $83.8M; 2026 revenue up to $50M.AQSTQ4 20255 Mar 2026
- Anaphylm sublingual film targets FDA approval in Q1 2027, aiming to disrupt the allergy market.AQSTOppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026
- Anaphylm sublingual film targets rapid, needle-free anaphylaxis relief with U.S. launch in 2025.AQSTH.C. Wainwright 27th Annual Global Investment Conference3 Feb 2026
- FDA requires new human factors and PK studies; resubmission targeted for Q3 2026.AQSTStatus update2 Feb 2026
- Q2 revenue up 52%, net loss narrows, and Anaphylm/Libervant advance toward key milestones.AQSTQ2 20242 Feb 2026
- Anaphilm, an oral epinephrine film, aims to transform allergy care and drive major market growth.AQSTH.C. Wainwright 26th Annual Global Investment Conference21 Jan 2026
Next Aquestive Therapeutics earnings date
Q1 202614 May, 2026
Aquestive Therapeutics
Next Aquestive Therapeutics earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage